AZENCO4 LIMITED
AZENCO4 Limited is a business support services entity registered at the Cambridge headquarters of the AstraZeneca pharmaceutical group.
Get an alert when AZENCO4 LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
£2.5B
USD 3,359,000,000
-15.3% vs 2024
Employees
—
Average over period
Profit before tax
£645M
USD 862,000,000
+613.1% highest in 3 filed years
Net assets
3-year trend · vs Industrials median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | £42,671,059 | -£198,382,991 | £545,740,380 | +375.1% | |
| Profit before tax | £45,665,519 | -£125,767,330 | £645,306,184 | +613.1% | |
| Net profit | £45,665,519 | -£125,767,330 | £645,306,184 | +613.1% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | — | £2,970,504,567 | £2,514,597,994 | -15.3% | |
| Net assets | £938,763,288 | £2,970,504,567 | £2,514,597,994 | -15.3% | |
| Equity | £938,763,288 | £2,970,504,567 | £2,514,597,994 | -15.3% | |
| Average employees | 0 | 0 | — | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | £0 | £0 | — | — |
Figures converted to GBP from USD at 0.749 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Return on capital employed | — | -6.7% | 21.7% | |
| Gearing (liabilities / total assets) | — | 0.0% | 0.0% |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“After making enquiries, the Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Based on their assessment of the Company's financial position, they continue to adopt the going concern basis in preparing the Financial Statements.”
Significant events
- “On 10 February 2026, the Company declared and paid an interim dividend of $0.02744 per share amounting to $69m to AstraZeneca Treasury Limited.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JOHNSTONE, Camilla Jane | Secretary | 2019-09-06 | — | — |
| BOWDEN, Matthew Shaun | Director | 2019-02-27 | Dec 1977 | British |
| COLLINS, Iain Alistair | Director | 2017-05-31 | Dec 1970 | British |
| TATTERSALL, Hannah Victoria | Director | 2025-05-01 | Jul 1987 | British |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CONACHER, Matthew Ian | Secretary | 2017-03-16 | 2019-09-06 |
| BRIMICOMBE, Ian Martin David | Director | 2016-01-22 | 2017-05-31 |
| JACKSON-TURNER, Katie Louise | Director | 2017-03-16 | 2019-02-27 |
| KEMP, Adrian Charles Noel | Director | 2016-01-22 | 2025-05-01 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Astrazeneca Treasury Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 58 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-06-25 RESOLUTIONS Resolution
- 2024-11-27 RESOLUTIONS Resolution
- 2024-11-27 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-19 | AA | accounts | Accounts with accounts type full | |
| 2026-01-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-06-25 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2025-06-25 | SH20 | capital | Legacy | |
| 2025-06-25 | CAP-SS | insolvency | Legacy | |
| 2025-06-25 | RESOLUTIONS | resolution | Resolution | |
| 2025-06-02 | AA | accounts | Accounts with accounts type full | |
| 2025-05-02 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-11-27 | RESOLUTIONS | resolution | Resolution | |
| 2024-11-27 | MA | incorporation | Memorandum articles | |
| 2024-08-09 | SH01 | capital | Capital allotment shares | |
| 2024-07-02 | SH01 | capital | Capital allotment shares | |
| 2024-05-28 | AA | accounts | Accounts with accounts type full | |
| 2024-01-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-03 | AA | accounts | Accounts with accounts type full | |
| 2023-01-31 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-08-16 | CH01 | officers | Change person director company with change date | |
| 2022-08-04 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 4
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.